Background: IgE reactivity to antigens from Gram-positive and Gram-negative bac-
| INTRODUCTION
Already in 1932, Cooke suggested that allergic sensitization to bacteria may play a role in asthma. 1 Since then, IgE sensitization to bacterial antigens has been reported for different manifestations of allergy. Several studies have observed IgE sensitization to bacterial antigens in children suffering from asthma. [2] [3] [4] In particular, IgE antibodies directed against enterotoxins from Staphylococcus aureus (S. aureus) were found to be associated with severe forms of asthma 5, 6 and recently
Staphylococcal serine protease-like proteins were suggested as pacemakers of allergic airway reactions to S. aureus.
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The occurrence of IgE to bacterial antigens was also observed in atopic dermatitis (AD) patients as early as 1981. [8] [9] [10] [11] [12] Anti-Staphylococcal IgE has been found in atopic dermatitis patients with or without cutaneous Staphylococcal infection, [8] [9] [10] [11] [12] and IgE reactivity against various antigens such as Staphylococcal exotoxins 13 and S. aureus fibronectin-binding protein 14 has been reported. In addition to IgE reactivity against Staphylococcal antigens, IgE reactivity to Escherichia coli (E. coli) antigens and other bacteria of the gut has been detected in about one-third of patients with AD. 15 These findings are unexpected, considering that S. aureus typically induces Th1 or Th17 rather than Th2 immune responses, and nonpathogenic E. coli is associated with immune tolerance rather than with allergic sensitization. 16, 17 Staphylococcus aureus (S. aureus) is present in the skin of patients with AD who frequently suffer from S. aureus superinfections, and it has therefore been suggested that sensitization occurs via the skin. 17 By contrast, E. coli and other bacteria (eg, Haemophilus influenza)
which have been reported as sources for IgE-reactive antigens 3, 4, 15 can be found mainly in the gut and in the respiratory tract, suggesting that other routes and mechanisms of allergic sensitization may be important. Recently, the genome, transcriptome and microbiome of house dust mites (HDM) one of the most frequent and potent allergen sources have been reported. 18 More than 50% of atopic individuals have allergic sensitization to HDM, particularly in environments with favourable conditions for mite proliferation, [19] [20] [21] and sensitization to HDM is common in patients suffering from respiratory and skin manifestations. 20, 22, 23 Interestingly, the microbiome of
Dermatophagoides farinae comprises a variety of Gram-positive and
Gram-negative bacteria, among them S. aureus, E. coli and Enterobacteria. 18 The description of the HDM microbiome has contributed to a growing body of evidence highlighting that HDM not only contain allergens but also other components such as bacterial adjuvant compounds which can activate the innate immune system. 24, 25 Here, we hypothesized that HDM may have another hitherto unknown role in allergic sensitization. In fact, we investigated whether HDM are carriers of microbial antigens that could cause a 
| Detection and measurement of specific IgE and IgG antibodies
IgG and IgE antibodies specific for S. aureus and E. coli were detected by immunoblotting. 15 Bacterial extracts were added to Laemmli SDS sample buffer, 27 boiled for 5 minutes and separated by SDS-PAGE on a 12.5% SDS polyacrylamide gel. 37 As HDM extracts were already prepared in Laemmli SDS sample buffer, the HDM protein extracts were loaded directly on 12.5% SDS polyacrylamide gels for electrophoretic separation. Aliquots of 50 lg, of each of the extracts were loaded per centimetre of a preparative gel, and a pre- IgE levels above 5000 kU/L were diluted in ImmunoCAP sample buffer to obtain the actual total IgE levels.
| Immunoblot and ImmunoCAP IgE inhibition assays
In IgE immunoblot inhibition experiments, 1/10 diluted plasma/ serum samples were preincubated overnight (4°C) with 200 lg of E. coli extract or for control purposes, with 0.5% bovine serum albumin and then tested for IgE reactivity to nitrocellulose-blotted HDM or E. coli extract. 39 The ImageJ software 43 was used to analyse and quantify the intensity of bands observed on the autoradiographs.
The reduction in density of bands from samples preincubated with bovine serum albumin compared to samples preincubated with E. coli extract was expressed as % inhibition of IgE binding. and risk ratio estimates, differences in proportions, differences in medians and the corresponding 95% confidence intervals were calculated. All calculated probability (P) values were two-tailed, and P values <.05 were considered statistically significant. Venn diagrams were generated using the Biovenn Web application http://www.cmb i.ru.nl/cdd/biovenn/. Patients with AD showed IgE reactivity to several different bands in S. aureus and E. coli extracts as exemplified in Figure 1 . However, no major IgE-reactive antigens recognized by more than 50% of the patients could be identified when the complete immunoblot data were evaluated (data not shown). IgE reactivity to at least one band in S. aureus and E. coli was observed in 21% (n = 38) and 25% The frequency of IgE sensitization to HDM allergens was 25% among the Swedish AD patients, when measured by the allergen chip ( Table 1) . 28 Sensitization to HDM allergens was therefore considerably lower in the Swedish AD patients than in the Austrian and German AD patients (ie, more than 50%) who had been analysed for IgE reactivity to bacterial antigens earlier.
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Age and gender distribution did not differ significantly between Swedish AD participants with HDM allergy and those without HDM allergy (Table S2A ). However, HDM-sensitized AD patients had significantly higher levels of total IgE than HDM-nonsensitized AD patients ( Figure S1 , Table S2A ).
| The frequency of IgE sensitization to bacterial
antigens is significantly higher in patients with AD sensitized to HDM
As it has been reported that the microbiome of HDM contains various bacteria, including S. aureus and E. coli, 18 we were wondering whether IgE sensitization to bacterial antigens may be associated with IgE sensitization to HDM. We therefore investigated the frequencies of sensitization to bacterial antigens in AD patients with and without HDM sensitization (Table 1 ). This analysis showed that 40% and 58% of HDM-sensitized AD patients had IgE antibodies specific for S. aureus and E. coli, respectively, whereas only 15% and 14% of AD patients without HDM sensitization showed IgE reactivity to S. aureus and E. coli. IgE reactivity to S. aureus and/or E. coli was present in 67% of the HDM-sensitized patients but only in 22% of those without HDM sensitization. The odds ratios for having IgE antibodies against E. coli, S. aureus or one of the two were 8.3, 3.8 and 7.2 in the HDM-sensitized vs the HDM-nonsensitized AD patients, respectively ( Table 1 ). The detailed frequencies of bacterial IgE sensitization among the HDM-sensitized and HDM-nonsensitized Swedish AD patients are depicted in the form of Venn diagrams in Figure 2 .
Age and gender distribution did not differ significantly between participants with bacterial IgE and those without bacterial IgE (Table S2B -D).
| IgE sensitization to bacterial antigens but not
to HDM allergens is associated with severe AD Figure 3 shows the proportion of patients with severe AD, history of rhinitis and history of asthma among patients with or without IgE reactivity to HDM allergens and bacterial antigens. Table S2 provides detailed information regarding the numbers, gender and age of the patients in the different groups and concerning significant differences regarding the presence of moderate or severe AD and history of rhinitis and asthma in the groups with HDM and bacterial IgE sensitizations. We found that IgE reactivity to HDM and to S. aureus and/or E. coli was associated with rhinitis. Having IgE against HDM or IgE specifically against E. coli had a relative risk of 1.24 (P = .0306) associated with rhinitis ( Figure 3 , Table S2A ,D). IgE reactivity to S. aureus and/or E. coli was also associated with severe AD (ie, relative risk 1.68; P = .0359) ( Figure 3 , Table S2B ). In particular, AD patients with IgE antibodies against S. aureus had an almost twofold increase in the relative risk (1.91; P = .0093) associated with severe AD compared to AD patients without IgE antibodies against S. aureus antigens ( Figure 3 , Table S2C ). Interestingly, we did not find associations between asthma or severe AD and IgE sensitization to HDM allergens in this population ( Figure 3 , Table S2A ).
| HDM contain bacterial antigens
To search for the presence of bacterial antigens in HDM, we prepared extracts from HDM bodies, separated them by SDS-PAGE and used rabbit antisera raised against S. aureus extract, E. coli extract or E. coli proteins, to detect S. aureus and E. coli antigens by immunoblotting ( Figure 4 ). The antiserum raised against S. aureus extract reacted specifically with a 25 kDa band in nitrocellulose-blotted HDM extract, whereas no reactivity was observed with the preimmune rabbit serum or the buffer control ( Figure 4) . Likewise, antisera raised against E. coli extract (anti-E. coli.1), and against low to high molecular weight E. coli For control purposes, we tested rabbit sera raised against purified HDM allergens (nDer p 1, rDer p 2, rDer p 5, rDer p 7, rDer p 10, 
| HDM contain IgE-reactive bacterial antigens
To detect IgE-reactive bacterial antigens in HDM, we then performed IgE immunoblot inhibition experiments 39 using serum/plasma samples where sufficient volumes were available. We tested whether preadsorption of plasma/sera from patients with AD with E. coli extract can inhibit IgE binding to blotted HDM extract ( Figure 5) . Table S1 provides a description of the clinical features and IgE reactivity profiles of the patients used in the IgE inhibition experiments.
Two of these patients (A3 and 004AD, Table S1 ) showed high IgE levels to Der p 2 at approximately 13 kDa ( Figure 5 ), which is well represented in HDM extracts. 20, 36 Patient A5 showed only very low IgE levels to Der p 2. Patients A1, A2, A3 and A5 showed IgE reactivity to Der p 23 which is poorly represented in extracts obtained from HDM bodies, 36 and patient A4 (Table S1 ) did not show IgE 
| Quantification of IgE towards bacterial antigens in HDM extracts
The IgE immunoblot inhibition experiments demonstrated that extracts from HDM contain IgE-reactive bacterial antigens. We were therefore interested to quantify the IgE levels towards bacterial antigens by ImmunoCAP TM inhibition experiments. Figure 6 shows the percentages of inhibition of IgE binding, which could be obtained when patients' plasma/sera ( Figure 6 , Table S1 ) were preadsorbed with E. coli extract and the remaining IgE towards HDM was determined by Der p ImmunoCAP TM measurements. We found that preadsorption of plasma/serum samples with E. coli extract inhibited IgE binding to HDM to varying extents and reached almost 50% (percentages inhibition: 0%-49%). For control purposes, we included a plasma sample from a patient (010AD) who was positive for IgE binding only to S. aureus but not to E. coli (Table S1 ). No reduction in IgE binding was observed in this sample after preincubation with E. coli extract ( Figure 6 ).
| DISCUSSION
HDM not only represent one of the most potent and frequent allergen sources worldwide, but they also contain factors that alter barrier function, induce pro-inflammatory cytokines and affect IgE responses as well as the innate immune system. 25 Recently, it has been reported that the HDM microbiome contains a variety of
Gram-positive and Gram-negative bacteria including S. aureus and E. coli. 18 These bacteria seem to be important as part of the HDM microbiome because mites do not thrive when cultured with antibiotics, 45 suggesting that bacteria exist as real endosymbionts of HDM and are not mere contaminants. In this study, we have investigated the hypothesis that HDM may have another important hitherto unknown function in allergy, namely to act as carriers for bacteria and thus participate in IgE sensitization to bacterial antigens. In fact, IgE sensitization to bacteria is common in respiratory and skin manifestations of allergy, [2] [3] [4] [5] [6] [7] 13, 15 but the mechanism of sensitization, particularly to Gram-negative bacteria such as E. coli, has been unknown.
We provide evidence that HDM are indeed carriers for IgE sensitization to bacterial antigens via two major approaches. First, we have investigated a well-defined group of patients with AD from Sweden, a country where HDM allergy is less frequent compared to other countries due to the dry and cold temperate climate. 26 We therefore could compare the frequencies of IgE sensitizations to bacterial antigens in HDM-sensitized and HDM-nonsensitized AD F I G U R E 5 Pre-incubation of plasma/serum samples from patients (A1-A5, 004AD) with IgE reactivity to bacterial antigens with an Escherichia coli (E. coli) extract inhibits IgE binding to distinct antigens in blotted house dust mites (HDM) extracts. IgE reactivity of plasma/ serum samples which had been preincubated with E. coli extract or BSA (negative control) to nitrocellulose-blotted HDM extracts. Buffer controls represent buffer without addition of plasma/serum. Bands that were inhibited by adsorption with E. coli are boxed, and the % reduction determined by densitometry in band density is given below. Table S3 ) which in previous studies has been shown to identify bona fide most of the HDM-sensitized patients. [40] [41] [42] In fact, we found that a considerable percentage of IgE which seemed to be specific for HDM allergen extract could be preadsorbed with bacterial antigens indicating that these patients were sensitized to bacteria rather than to HDM. Therefore, the possibility that IgE sensitization to bacterial antigens may cause a false-positive test result with HDM extracts containing bacteria when diagnostic tests are performed with HDM extract needs to be considered.
In a previous study from our group, 15 we addressed the question whether IgE reactivity to bacterial antigens is due to high total IgE levels, and we found that high IgE levels were not a prerequisite for reactivity to bacterial antigens. In our current study, we observed that even though elevated total plasma IgE levels were associated with IgE reactivity to either S. aureus or E. coli, not all AD patients with high IgE showed reactivity to the bacterial extracts (S. aureus IgE-negative sample with IgE 2800 kU/L; E. coli IgE-negative sample with IgE 10 600 kU/L), and some patients with relatively low total IgE levels had IgE to bacteria (S. aureus IgE-positive sample with IgE 38 kU/L; E. coli IgE-positive sample with IgE 150 kU/L). Elevated total plasma IgE is therefore not a prerequisite for IgE binding to bacterial antigens.
IgE sensitization to bacterial antigens, particularly from S. aureus, has been shown to be clinically relevant in respiratory allergy and AD. 3, 5, 14 Sensitization to Gram-negative bacteria (eg, H. influenzae) may also have protective activity, 2,4,46 but the clinical relevance of IgE sensitization to E. coli has not been investigated so far. It is, however, possible that IgE against E. coli may play a role in gastrointestinal manifestations that mimic food allergy, and such gastrointestinal disturbances are quite common in patients with AD. [47] [48] [49] In summary, the results of our study demonstrate that HDM can act as a carrier for antigens from bacteria which colonize the skin, the respiratory tract and the gut and thus may cause sensitization to bacterial antigens. This could explain the frequent occurrence of IgE 
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